Moran Wealth Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.16M Buy
7,767
+481
+7% +$184K 0.09% 264
2026
Q2
$2.9M Buy
7,286
+2,560
+54% +$1.12M 0.08% 273
2026
Q1
$2.18M Sell
4,726
-278
-6% -$141K 0.07% 293
2025
Q4
$2.83M Buy
5,004
+1,431
+40% +$762K 0.09% 254
2025
Q3
$1.6M Buy
3,573
+1,097
+44% +$526K 0.05% 298
2025
Q2
$1.35M Buy
2,476
+757
+44% +$396K 0.04% 305
2025
Q1
$851K Sell
1,719
-59
-3% -$32.6K 0.03% 316
2024
Q4
$928K Buy
1,778
+29
+2% +$15.1K 0.03% 304
2024
Q3
$859K Buy
1,749
+341
+24% +$159K 0.03% 306
2024
Q2
$626K Buy
1,408
+366
+35% +$146K 0.02% 324
2024
Q1
$416K Buy
1,042
+316
+44% +$119K 0.01% 340
2023
Q4
$245K Buy
+726
New +$216K 0.01% 377
2023
Q1
– Sell
-18,768
Closed -$4.98M – 364
2022
Q4
$4.98M Buy
+18,768
New +$4.58M 0.19% 149

Other funds holding ISRG

Moran Wealth Management's ISRG Position: Q3 2026 in Review

Moran Wealth Management increased its Intuitive Surgical (ISRG) stake by 6.6% in Q3 2026, buying an estimated $184K and bringing the position to 7,767 shares worth $3.16M. The position accounts for 0.09% of the portfolio, ranked #264.

Moran Wealth Management first reported a position in ISRG in Q4 2022 and has held it in 13 quarters since. The position peaked at $4.98M in Q4 2022. 526 funds tracked by Wall St. Rank hold ISRG as of Q3 2026.

  • Moran Wealth Management held 7,767 shares of Intuitive Surgical worth $3.16M as of Q3 2026.
  • Moran Wealth Management bought 481 Intuitive Surgical shares in Q3 2026, an estimated $184K.
  • Intuitive Surgical made up 0.09% of Moran Wealth Management's portfolio in Q3 2026, its #264 holding.
  • Moran Wealth Management first reported a position in Intuitive Surgical in Q4 2022 and has held it in 13 quarters since.
  • Moran Wealth Management's Intuitive Surgical position peaked at $4.98M in Q4 2022.
  • 526 funds tracked by Wall St. Rank held Intuitive Surgical as of Q3 2026.

Based on Moran Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.